<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134536">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01977079</url>
  </required_header>
  <id_info>
    <org_study_id>CHD061-13</org_study_id>
    <nct_id>NCT01977079</nct_id>
  </id_info>
  <brief_title>Procalcitonin and Threatened Premature Delivery</brief_title>
  <acronym>MAPPRO</acronym>
  <official_title>Procalcitonin and Threatened Premature Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among all patients hospitalized for Threatened Premature Delivery (TPD), the rate of
      premature birth (PB) before 37 weeks is about 42%, which reflects the inability to
      accurately identify patients at high risk of PB. Currently, no clinical or biological marker
      is recognized as the most reliable in predicting the real risk of AP in case of MAP.

      The purpose of this study is to improve the knowledge of predictors of preterm delivery
      compared with conventional blood markers by estimating serum procalcitonin according to
      premature delivery or not in patients hospitalized for preterm labor .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>procalcitonin rate</measure>
    <time_frame>up to 48 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Estimate serum procalcitonin according to premature or not in patients hospitalized for preterm labor.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pregnancy</condition>
  <condition>Premature Delivery</condition>
  <arm_group>
    <arm_group_label>Premature birth</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At the end of the study patients will be divided into two groups: &quot;Premature delivery&quot; versus &quot;No premature delivery.&quot; Prematurity is defined as a birth before 37.
In each group, the procalcitonin rate be estimated with a confidence interval of 95% and compared from a logistic regression.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not premature birth</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At the end of the study patients will be divided into two groups: &quot;Premature delivery&quot; versus &quot;No premature delivery.&quot; Prematurity is defined as a birth before 37.
In each group, the procalcitonin rate be estimated with a confidence interval of 95% and compared from a logistic regression.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>procalcitonin</intervention_name>
    <arm_group_label>Premature birth</arm_group_label>
    <arm_group_label>Not premature birth</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 year

          -  Ongoing pregnancy with a start date of pregnancy known and confirmed by an ultrasound
             of the 1st Quarter performed between 10 and 14 weeks with a measurement of the
             crown-rump length

          -  hospitalization for preterm labor between 24 and 36 weeks of gestation

          -  Intact membranes,

          -  not opposed to participate in the study

        Exclusion Criteria:

          -  Pregnancy uncertain term (no early ultrasound)

          -  Pregnancy combining a condition that can interfere with the assays performed,

          -  Uterine malformation known

          -  Multiple pregnancy,

          -  Premature rupture of membranes,

          -  Chrorio-amnionitis,

          -  Fetal malformation known

          -  Strapping

          -  GB&gt; 15000 and CRP&gt; 10 mg / L,

          -  No affiliation to a social security scheme.

          -  Woman with a measure of legal protection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume DUCARME, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier départemental Vendée</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier départemental Vendée</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucie AUZANNEAU</last_name>
      <phone_ext>33</phone_ext>
      <email>lucie.auzanneau@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume DUCARME, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>December 5, 2013</lastchanged_date>
  <firstreceived_date>October 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>premature birth</keyword>
  <keyword>procalcitonin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obstetric Labor, Premature</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
